[{"indications": "Indications\u00a0adjunct in the treatment of female infertility (under specialist\r\nsupervision)", "name": "CETRORELIX", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.7 Other endocrine drugs", "6.7.2 Drugs affecting gonadotrophins", "CETRORELIX"], "side-effects": "Side-effects\u00a0nausea, headache, injection site reactions; rarely\r\nhypersensitivity reactions", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/78257.htm", "doses": ["By subcutaneous injection into the\r\nlower abdominal wall,", "either 250\u00a0micrograms in the morning, starting\r\non day 5 or 6 of ovarian stimulation with gonadotrophins (or each evening starting on day 5 of ovarian stimulation);\r\ncontinue throughout administration of gonadotrophin including day\r\nof ovulation induction (or evening before ovulation\r\ninduction)", "or 3\u00a0mg on day 7 of ovarian stimulation with\r\ngonadotrophins; if ovulation induction not possible on day 5 after\r\n3-mg dose, additional 250\u00a0micrograms once daily until day of ovulation\r\ninduction"], "pregnancy": "Pregnancy\u00a0avoid in confirmed pregnancy"}]